UPDATED on Dec. 11, 2018 with photo from the Dec, 10, 2018 ceremony.
ORIGINAL STORY: James P. Allison, Ph.D., an immunologist at The University of Texas MD Anderson Cancer Center, is in Sweden to receive the 2018 Nobel Prize in Physiology or Medicine jointly with Japanese immunologist Tasuku Honjo, M.D., Ph.D.
The pair were announced on Oct. 1 as laureates for the discovery of cancer therapies that stimulate the immune system to attack tumor cells. Treatments developed from Allison’s work have extended the lives of thousands of people with advanced disease, though certain cancers have responded better to immunotherapy than others.
Allison delivered his Nobel lecture entitled “Immune Checkpoint Blockade in Cancer Therapy: New insights, opportunities, and prospects for cures” on Dec. 7 in Stockholm.
Both Allison, 70, and Honjo, 76, made discoveries that led to the development of “checkpoint inhibitors”—drugs infused into patients to block molecules that put the brakes on T cells. By releasing these brakes, the body’s own immune system is able to fight cancer.
Each scientist will receive a Nobel medal and diploma. They will also share a nearly $1 million prize.
According to MD Anderson, Allison has been busy during Nobel Week in Sweden. On Thursday, he signed the bottom of a chair at Bistro Nobel in the Nobel Museum in Stockholm’s Old Town. The ritual is part of a traditional museum visit by Nobel winners and launches the week’s events.
Laureates traditionally donate artifacts to the Nobel Museum. Allison presented the museum with the following items:
- A vial representing 9H10, a mouse-model monoclonal antibody developed in his lab in 1995 to block CTLA-4, a protein on T cells that shuts down immune response
- A vial of ipilimumab from Bristol-Myers Squibb that was developed for human use based on Allison’s work
- The first page of a 1996 article in Science that reported the success of anti-CTLA-4 treatment in freeing T cells to attack cancer in mice
- The first page of a 2015 review in Cell that was co-authored by Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at MD Anderson, who is the scientist’s longtime research collaborator and spouse
- A portrait of Allison and Sharma taken by a Dallas photographer
Allison is the first Nobel laureate for MD Anderson, where he is a professor and chair of the department of immunology. He is the executive director of the Immunotherapy Platform, which is part of MD Anderson’s Moon Shots Program—an ambitious effort to more rapidly reduce cancer deaths and suffering by developing advances in prevention, early detection and treatment based on scientific discoveries. In addition, Allison holds the Vivian L. Smith Distinguished Chair in Immunology and serves as deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers in the department of genitourinary medical oncology.
Read more about Allison in this profile published in the November 2018 issue of TMC Pulse.
It’s a full house at UTMB’s annual Employee Service Day! Congratulations to all of our employees celebrating today and thank you for your outstanding service! https://t.co/NG8TqNmAnm
Harris Health System@harrishealth
May is International Mediterranean Diet Month. Get in the spirit with this Mediterranean Diced Salad made with flavorful, nutritious chickpeas. https://t.co/iDHXhsttod https://t.co/5qGP5hgIfo
The nation’s top medical experts, hospital executives, pediatricians and community health leaders recently convened at @TexasChildrens for @usnews “Combatting Childhood Obesity” summit, addressing one of the nation’s most critical health issues: https://t.co/ZfeU7kEOwB
TAMU Health Sciences@TAMHSC
@NurseKnut @TAMU Thank you for your selfless service, life savers!👍
RT @BCM_CancerEd: Summer is almost here, do you have the right sun protection products? The @SkinCancerOrg and @AADskin give recommendation…
MD Anderson Cancer Center@MDAndersonNews
#Mealplanning tips to help you make healthier food choices, while saving time and money, from our dietitian Lindsey Wohlford: https://t.co/FSjXRUl8UK @FocusedonHealth #endcancer https://t.co/UWAGalotCh
3-D printing technology brings innovation to @SanAntonioVAMC https://t.co/fGVG1p4ki7 via #VAntagePoint
RT @BCMHouston_News: A new study shows practicing dawn to sunset fasting for 30 days may potentially help treat #obesity-related conditions…
University of Houston@UHouston
@JRUG_17 Just chillin' https://t.co/nahz4T5ZSr
A bloody nose whether it comes from an injury or just out of the blue can be alarming. Dr. Eddie Liou shares some tips on how to manage the bleed. https://t.co/eQcSzNCtvw #nosebleeds
Try this delicious and fizzy—but also healthy—drink at your next get-together: https://t.co/GdY9NEq0Ir. https://t.co/vyj5TUj3IC
RT @MoodyArts: We're excited to share that the Moody Center for the Arts, designed by Michael Maltzan Architecture, is a recipient of the T…
MD Anderson Cancer Center@MDAndersonNews
“There was no question I’d go to MD Anderson for my #tonsilcancer treatment,” says survivor Jeff Deatsman: https://t.co/60zRSzp7vA @mekupferman @CD_fuller #HPV #hncsm #endcancer
RT @RiceUNews: Houston’s new poet laureate is not only a @RiceUniversity employee, she's also a @ricealumni: "Rice absolutely helped me get…
@Rob_Zelinka Rob, we apologize for the frustrating experience. Please contact our Family Advocacy department at 832-824-1919 to share any additional details about your visit. Thank you for reaching out to us.